l.pires
TL2 · Aarhus
Contributes reviews on supplier material. Based in Aarhus.
Joined 19 February 2025 · last posted 3d · groups: regional-na
83Posts here
4Topics
1Solutions
1.1kLikes received
1.7kLikes given
25Badges
230Days visited
5.2kPosts read
Recent activity
Full stream-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #95 · Practice › Dosing & titration · 25 Jul 2026 · 4 likes If you are stepping up mainly because the schedule says so rather than because the current dose has stopped doing what you wanted, that is worth noticing before rather…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #13 · Compounds › Tirzepatide · 21 Jul 2026 · 0 likes The arithmetic in post #10 is right; the assumption feeding it is the part to check. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long.…
-
Which categories are strict and which are relaxed, honestly Replied, post #24 · Start Here › Welcome · 17 Jul 2026 · 2 likes One small courtesy that makes a large difference: put the specific question in the title. It is the single thing that most changes how quickly you get a useful reply.…
-
Common supplements people ask about, assessed one at a time Replied, post #56 · Practice › Interactions · 16 Jul 2026 · 25 likes Anything that also slows gut motility compounds the same mechanism. That is a plausibility argument rather than a documented interaction, and it should be labelled as…
-
Blinding yourself: practical methods and their limits — the long version Replied, post #10 · Research Methods › N-of-1 designs · 16 Jul 2026 · 18 likes The best thing about this subcategory is that people post their protocols before their results. That order is what keeps it honest. That is my reading. Someone else…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #32 · Access › Insurance & coverage · 15 Jul 2026 · 3 likes Narrowing post #31, because the general version has more than one answer. Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #82 · Analytics › Home & field testing · 13 Jul 2026 · 0 likes Adding the measurement that post #79 says would settle it. The honest cost comparison is a home kit against a single independent submission. For most people the second…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #15 · Practice › Interactions · 11 Jul 2026 · 8 likes Confirming post #14 from a second method, which matters more than confirming it from a second person. Delayed gastric emptying is the mechanism behind most of the…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #38 · Evidence › Journal club · 8 Jul 2026 · 15 likes The claim about SUSTAIN 6 upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
-
A structured critique template this community uses — a second dataset Replied, post #30 · Evidence › Study critique · 6 Jul 2026 · 4 likes Everything in post #26 holds. The case it does not cover is the one I have. On structured critique template the community has more anecdote than the confidence in this…
-
Tracking a shortage from primary sources rather than rumour Replied, post #84 · Access › Shortages · 4 Jul 2026 · 9 likes Post #81 is the version of this I will quote in future. One addition. International supply chains: a shortage in one country does not mean shortage in another. That is…
-
Alcohol: what is documented and what is folklore Replied, post #84 · Practice › Interactions · 30 Jun 2026 · 0 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.